Stanford AI Tool Predicts Cancer Gene Activity from Biopsy Images, Potentially Revolutionizing Cancer Diagnosis

3 Sources

Stanford Medicine researchers have developed an AI-powered tool called SEQUOIA that can predict gene activity in cancer cells using only biopsy images, potentially speeding up diagnosis and treatment decisions while reducing costs.

News article

Stanford Researchers Develop AI Tool to Predict Cancer Gene Activity

Stanford Medicine researchers have developed an innovative artificial intelligence (AI) tool that could revolutionize cancer diagnosis and treatment planning. The computational program, named SEQUOIA (slide-based expression quantification using linearized attention), can predict the activity of thousands of genes within tumor cells based solely on standard microscopy images of biopsy samples 1.

How SEQUOIA Works

SEQUOIA was developed using data from 7,584 cancer biopsies across 16 different cancer types. The AI model analyzes thin sections of tumor biopsies prepared with hematoxylin and eosin staining, a standard method for visualizing cancer cells 2.

By integrating this data with transcriptomic information and images from thousands of healthy cells, SEQUOIA can predict the expression patterns of more than 15,000 different genes from the stained images. For some cancer types, the AI-predicted gene activity showed over 80% correlation with actual gene activity data 3.

Potential Impact on Cancer Diagnosis and Treatment

Traditional methods of determining genomic changes driving tumor growth require genetic sequencing of RNA isolated from the tumor, a process that can take weeks and cost thousands of dollars. SEQUOIA could potentially bypass this need, offering several advantages:

  1. Speed: The AI tool can quickly identify gene signatures in patients' tumors, accelerating clinical decision-making.
  2. Cost-effectiveness: By reducing the need for expensive genetic sequencing, SEQUOIA could save the healthcare system significant amounts of money.
  3. Comprehensive analysis: The tool can predict the activation of large genomic programs, which is often more clinically relevant than individual gene expression.

Promising Results in Breast Cancer

To test SEQUOIA's clinical utility, the researchers focused on breast cancer, a well-studied cancer type with established gene signatures correlated to treatment responses and patient outcomes 1.

The team demonstrated that SEQUOIA could provide genomic risk scores comparable to the FDA-approved MammaPrint test, which analyzes 70 breast-cancer-related genes. Patients identified as high-risk by SEQUOIA showed worse outcomes, including higher rates of cancer recurrence and shorter time before recurrence 2.

Future Prospects and Limitations

While SEQUOIA shows great promise, it is not yet ready for clinical use. The tool needs to undergo clinical trials and receive FDA approval before it can be used to guide treatment decisions. However, the research team, led by Olivier Gevaert, PhD, a professor of biomedical data science at Stanford, is continually improving the algorithm and exploring its potential applications 3.

The development of SEQUOIA represents a significant step forward in the integration of AI and genomics in cancer research and treatment. As the tool continues to evolve, it could potentially be applied to all cancer types, offering a new source of valuable data for oncologists and researchers alike.

Explore today's top stories

OpenAI Launches ChatGPT Agent: A New Era of AI-Powered Task Automation

OpenAI introduces ChatGPT Agent, a powerful AI assistant capable of performing complex tasks across multiple platforms, marking a significant advancement in agentic AI technology.

Ars Technica logoTechCrunch logoWired logo

46 Sources

Technology

23 hrs ago

OpenAI Launches ChatGPT Agent: A New Era of AI-Powered Task

TSMC Reports Record Profits Amid Surging AI Chip Demand, Raises 2025 Outlook

Taiwan Semiconductor Manufacturing Co. (TSMC) posts record-breaking quarterly profits, driven by strong demand for AI chips. The company raises its 2025 revenue growth forecast to 30%, signaling continued momentum in the AI sector.

Reuters logoQuartz logoSiliconANGLE logo

9 Sources

Technology

23 hrs ago

TSMC Reports Record Profits Amid Surging AI Chip Demand,

Slack Unveils AI-Powered Features to Enhance Workplace Productivity and Communication

Slack introduces a suite of AI-driven tools to improve search, summarization, and communication within its platform, aiming to streamline workplace collaboration and compete with other tech giants in the enterprise productivity space.

TechCrunch logoThe Verge logoZDNet logo

10 Sources

Technology

23 hrs ago

Slack Unveils AI-Powered Features to Enhance Workplace

Netflix Pioneers Use of Generative AI in TV Production, Sparking Efficiency and Controversy

Netflix has incorporated generative AI-powered visual effects in its Argentine sci-fi series "El Eternauta," marking a significant shift in TV production. While praised for efficiency and cost-effectiveness, the move raises concerns about AI's impact on the entertainment industry.

TechCrunch logoReuters logoBBC logo

10 Sources

Technology

8 hrs ago

Netflix Pioneers Use of Generative AI in TV Production,

Google Enhances AI Mode in Search with Gemini 2.5 Pro, Deep Search, and AI Calling Features

Google introduces advanced AI capabilities to Search, including Gemini 2.5 Pro integration, Deep Search for comprehensive research, and an AI agent for business inquiries.

Google Blog logoNDTV Gadgets 360 logoFoneArena logo

3 Sources

Technology

1 day ago

Google Enhances AI Mode in Search with Gemini 2.5 Pro, Deep
TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo